| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2850548 | American Heart Journal | 2014 | 9 Pages |
Abstract
The Gly389 variant in the β1-adrenoreceptor is associated with PoAF, and this association appears to be modulated by β-blocker therapy. Future studies of the association of other adrenergic pathway genes with PoAF will be of interest.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Janina M. PhD, Brian S. MD, PhD, Kristin MS, Dan M. MD, Dana C. PhD, C. Michael MD, Daniel MD,